Showing results (121-130 of 422) with videos related to

Sort By:
Pageof 43
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 24, 2001
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRIT Stuckensen, A F Kovács, S Adams, et al.
Clinical Nuclear Medicine|January 24, 2019
Delayed Response (Partial Remission) 3 Years After Peptide Receptor Radionuclide Therapy in a Patient Participating in the NETTER-1 TrialJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|January 25, 2020
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor AntagonistJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|March 27, 2020
177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal CarcinomaQingxing Liu, Jingjing Zhang, Harshad R Kulkarni, et al.
Revue Neurologique|April 15, 2008
[Primary brain stem hemorrhage: retrospective study of 25 cases]J S Raison, G Bourbotte, T P Baum, et al.
Clinical Nuclear Medicine|April 2, 2019
Prostate-Specific Membrane Antigen Accumulation in Lower Extremity LymphedemaJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Is there a correlation between peptide receptor radionuclide therapy-associated hematological toxicity and spleen dose?Harshad R Kulkarni, Vikas Prasad, Christiane Schuchardt, et al.
World Journal of Surgery|July 23, 1998
Late results of heterotopic autotransplantation of splenic tissue into the greater omentumT Weber, E Hanisch, R P Baum, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysisHendra Budiawan, Ali Salavati, Harshad R Kulkarni, et al.
Clinical Nuclear Medicine|December 27, 2019
Twelve-Year Survival of a Patient With Lymph Node, Pulmonary, Bone, Cardiac and Intraspinal Metastases of a Rectal Neuroendocrine Neoplasm Treated With Peptide Receptor Radionuclide Therapy-The Value of Salvage Peptide Receptor Radionuclide TherapyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Pageof 43